Synthesis of myelin glycosphingolipids (galactosylceramide and galactosyl(3-O-sulfate)ceramide (sulfatide)) by cloned cell lines derived from mouse neurotumors.
Clonal cell lines derived from both spontaneous and chemically induced rat and mouse brain tumors were screened for their ability to incorporate H232SO4 into galactosyl(3-O-sulfate)ceramide (sulfatide). High levels of 35SO4 incorporation into sulfatide were found only in two of the mouse cell lines studied (G26-20 and -24). Tumors produced by subcutaneous injection of these cell lines into C57BL/6 mice were also unique in that they contained high levels of both sulfatide and galactosylceramide. The synthesis of large amounts of sulfatide and galactosylceramide by a clonal cell line of neurological origin suggests that the original tumor was of oligodendrocyte or Schwann cell origin. In common with a large number of mouse and rat astrocyte cell strains and their derived tumors, these glial cells lacked the ability to synthesize gangliosides such as monosialotetraglycosylceramide and disialotetraglycosylceramide (as judged by analytical and [3H]GlcNH2 incorporation studies). This appears to be a unique characteristic of neuroblastoma-derived cell strains such as N18, NB2a, and NB41A.
D000818:Animals; D001932:Brain Neoplasms / Q000378:metabolism*; D002999:Clone Cells; D005910:Glioma / Q000378:metabolism*; D006028:Glycosphingolipids / Q000096:biosynthesis*; D051379:Mice; D009186:Myelin Sheath / Q000378:metabolism*; D009374:Neoplasms, Experimental / Q000378:metabolism; D013433:Sulfoglycosphingolipids / Q000096:biosynthesis*
D006028:Glycosphingolipids; D013433:Sulfoglycosphingolipids